ADVFN US – Market Content Editor
-
Barclays Expects Slower Equity Returns as Higher Interest Rates Challenge Market Outlook
Barclays strategists expect the global equity market to face more restrictive financial conditions as the monetary easing cycle draws to a close, although they continue to see scope for European stocks to advance towards the end of 2026. In a research note, strategists led by Emmanuel Cau said the equity bull market is “arguably running…
-
ECB’s Lane Says AI Investment Is Contributing to Higher Global Bond Yields
European Central Bank (ECB) chief economist Philip Lane has identified rising investment in artificial intelligence as a significant factor influencing global bond yields, pointing to increased long-term borrowing by U.S. companies financing AI-related projects. In an interview with Italian news agency ANSA published Tuesday, Lane described artificial intelligence as potentially the most important global economic…
-
UBS Forecasts Copper Supply Deficit of 379,000 Metric Tons in 2027, Targets $15,500 per Ton
UBS expects the global copper market supply deficit to widen in 2027, with the bank forecasting a shortfall of 379,000 metric tons, compared with an estimated 219,000 metric tons in 2026. The projected increase in the deficit forms part of UBS’s positive outlook for copper prices, with the bank anticipating that the metal could reach…
-
Memory Chip Prices Rise Nearly 20% in Third Quarter as Supply Shortages Persist, Bernstein Says
Memory chip contract prices increased by nearly 20% quarter-over-quarter in the third quarter of 2026, as supply shortages continued across the industry, according to research firm Bernstein. Contract pricing data showed increases in both conventional dynamic random-access memory (DRAM) and NAND flash memory during the quarter. Although the pace of price growth moderated compared with…
-
Wall Street Rebounds From AI Sell-Off as Oil Eases, Lifting All Major Indexes to Weekly Gains
U.S. stocks finished higher on Friday as a pullback in oil prices and a rebound in technology shares helped Wall Street recover from Thursday’s AI-driven slide. All four major indexes closed in positive territory, and the Dow Jones Industrial Average and S&P 500 both posted gains for the week. Investors are now looking toward next…
-
Mkango earns EU strategic status for third rare earths project
In a significant boost for European critical mineral independence, HyProMag’s rare earths magnet recycling facility in Pforzheim, Germany, has been officially designated as a strategic project under the EU Critical Raw Materials Act (CRMA). The status grants the facility—majority-owned by Mkango Magnetic Materials —expedited permitting and improved access to financing, bolstering its integration into Europe’s…
-
Northwest Biotherapeutics Announces NHSBT Collaboration to Support DCVax-L Production in the UK
Northwest Biotherapeutics (USOTC:NWBO) has entered into a collaboration with NHS Blood and Transplant to support manufacturing of its experimental DCVax-L cancer vaccine, strengthening UK production infrastructure while the treatment’s marketing authorisation application remains under regulatory review. Key Investor Takeaways Why NWBO Stock Is in Focus Northwest Biotherapeutics has announced a collaboration with NHS Blood and…
-
Veea Regains Full Nasdaq Listing Compliance After Resolving Governance Deficiencies
Veea Inc. (NASDAQ:VEEA) has restored full compliance with Nasdaq’s continued listing requirements following board restructuring and the earlier resolution of its minimum bid-price deficiency, removing previously disclosed regulatory concerns over its exchange listing. Key Investor Takeaways Why VEEA Stock Is in Focus Veea has confirmed that it now meets Nasdaq’s continued listing standards after completing…
-
Roche’s Genentech Secures FDA Approval for Tecentriq in Stage III Colon Cancer
Genentech, part of Roche Group (USOTC:RHHBY), has received FDA approval for Tecentriq in combination with chemotherapy for a specific form of stage III colon cancer, expanding the immunotherapy’s U.S. indications following positive Phase III clinical trial results. Key Investor Takeaways Why RHHBY Stock Is in Focus Genentech has secured U.S. Food and Drug Administration approval…
-
Vivakor Signs LOI for Proposed $40 Million Direct Midstream Acquisition in Permian Basin
Vivakor (NASDAQ:VIVK) has signed a non-binding letter of intent to acquire Direct Midstream, outlining a stock-heavy transaction that could expand its Permian Basin infrastructure and oilfield waste management operations. Key Investor Takeaways Why VIVK Stock Is in Focus Vivakor has established the principal financial terms for its proposed acquisition of 100% of Direct Midstream, a…